These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21106111)

  • 1. Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
    Kawabata Y; Tanaka T; Nishisaka T; Inao T; Nishi T; Yano S
    Diagn Pathol; 2010 Nov; 5():75. PubMed ID: 21106111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
    Zhou H; Schaefer N; Wolff M; Fischer HP
    Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
    Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
    Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
    Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
    Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM
    Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does ampullary carcinoma arise from distended glands in the papilla of Vater?
    Sonoue H; Suda K; Nobukawa B; Abe H; Arakawa A; Hirai S; Matsumoto T
    J Hepatobiliary Pancreat Surg; 2008; 15(2):161-8. PubMed ID: 18392709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20.
    Nishigami T; Onodera M; Torii I; Sato A; Tao LH; Kushima R; Kakuno A; Kishimoto M; Katsuyama E; Fujimori T; Hirano H; Satake M; Kuroda N; Nishiguchi S; Fujimoto J; Tsujimura T
    Pancreas; 2009 Jul; 38(5):558-64. PubMed ID: 19287335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
    Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A
    Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucins differently expressed in various ampullary adenocarcinomas.
    Wang T; Liang YM; Hu P; Cheng YF
    Diagn Pathol; 2011 Oct; 6():102. PubMed ID: 22027009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human fetal ductal plate revisited: II. MUC1, MUC5AC, and MUC6 are expressed in human fetal ductal plate and MUC1 is expressed also in remodeling ductal plate, remodeled ductal plate and mature bile ducts of human fetal livers.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):571-85. PubMed ID: 23573304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
    Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
    Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
    Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
    Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin.
    Zhao XQ; Dong JH; Zhang WZ; Liu Z
    Diagn Pathol; 2011 Oct; 6():98. PubMed ID: 21992455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.
    Betge J; Schneider NI; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
    Virchows Arch; 2016 Sep; 469(3):255-65. PubMed ID: 27298226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.